Scientists may have just come across a cure for hemophilia A, the most common type of condition that affects the blood’s ability to clot. British researchers Barts Health NHS Trust and Queen Mary University of London used a novel gene therapy drug. They found 85 percent of clinical trial participants showed normal levels of the essential…